James J. Donohue SEC EDGAR Filings (CIK 0001869107)

SEC EDGAR filings, ownership reports, and insider transactions for James J. Donohue.

Business address
C/O Acurx Pharmaceuticals, Inc., 259 Liberty Avenue, Staten Island, NY, 10305
Top holdings (ownership)
ACXP
Get insider transactions for this reporting owner
James J. Donohue has filed 5 SEC EDGAR filings since 24 Jun 2021

Latest Filings

Recent SEC filings for James J. Donohue including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 08 Jan 2025 06 Jan 2025 001-40536
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 18 Jun 2024 17 Jun 2024 001-40536
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 16 Jun 2023 15 Jun 2023 001-40536
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 06 Jul 2021 01 Jul 2021 001-40536
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 24 Jun 2021 24 Jun 2021 001-40536

About this filer

James J. Donohue files with the SEC under CIK 0001869107. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages